AKYA — Akoya Biosciences Income Statement
0.000.00%
Last trade - 00:00- $67.94m
- $118.00m
- $81.67m
- 45
- 50
- 17
- 30
Annual income statement for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 42.4 | 54.9 | 74.9 | 96.6 | 81.7 |
| Cost of Revenue | |||||
| Gross Profit | 25.9 | 34.2 | 43.4 | 56.3 | 47.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 56.1 | 91.7 | 141 | 154 | 128 |
| Operating Profit | -13.7 | -36.8 | -66.1 | -57.7 | -46.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -16.7 | -43.1 | -70.5 | -63.3 | -55.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -16.7 | -42.9 | -70.6 | -63.3 | -55.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -16.7 | -42.9 | -70.6 | -63.3 | -55.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21.8 | -44.4 | -70.6 | -63.3 | -55.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.579 | -1.71 | -1.87 | -1.43 | -1.04 |
| Dividends per Share |